Northern Financial Advisors Inc Has $1.91 Million Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Northern Financial Advisors Inc lifted its stake in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 7.0% during the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,636 shares of the healthcare conglomerate’s stock after acquiring an additional 237 shares during the period. UnitedHealth Group makes up 1.6% of Northern Financial Advisors Inc’s portfolio, making the stock its 10th largest holding. Northern Financial Advisors Inc’s holdings in UnitedHealth Group were worth $1,914,000 as of its most recent SEC filing.

Several other large investors have also recently bought and sold shares of the stock. Wellington Management Group LLP boosted its stake in UnitedHealth Group by 2.1% during the third quarter. Wellington Management Group LLP now owns 25,220,234 shares of the healthcare conglomerate’s stock worth $12,715,790,000 after buying an additional 527,526 shares in the last quarter. Northern Trust Corp grew its stake in shares of UnitedHealth Group by 3.6% in the 3rd quarter. Northern Trust Corp now owns 9,787,768 shares of the healthcare conglomerate’s stock valued at $4,934,895,000 after purchasing an additional 341,749 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in UnitedHealth Group by 0.5% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 5,843,207 shares of the healthcare conglomerate’s stock valued at $2,937,976,000 after buying an additional 27,127 shares in the last quarter. Sanders Capital LLC raised its stake in UnitedHealth Group by 6.5% during the third quarter. Sanders Capital LLC now owns 5,757,410 shares of the healthcare conglomerate’s stock worth $2,902,829,000 after acquiring an additional 352,710 shares in the last quarter. Finally, Ameriprise Financial Inc. boosted its stake in shares of UnitedHealth Group by 20.1% in the 3rd quarter. Ameriprise Financial Inc. now owns 3,725,650 shares of the healthcare conglomerate’s stock valued at $1,879,245,000 after purchasing an additional 623,631 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

UnitedHealth Group Trading Down 0.1 %

Shares of NYSE:UNH traded down $0.49 during mid-day trading on Wednesday, reaching $500.47. The stock had a trading volume of 1,127,342 shares, compared to its average volume of 4,340,719. The firm has a market cap of $460.47 billion, a PE ratio of 30.66, a price-to-earnings-growth ratio of 1.43 and a beta of 0.55. The firm has a 50 day simple moving average of $481.45 and a two-hundred day simple moving average of $511.98. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $554.70.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its quarterly earnings data on Tuesday, April 16th. The healthcare conglomerate reported $6.91 EPS for the quarter, beating analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a net margin of 4.05% and a return on equity of 26.50%. The business had revenue of $99.80 billion during the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter in the prior year, the company earned $6.26 EPS. The firm’s quarterly revenue was up 8.6% on a year-over-year basis. On average, research analysts predict that UnitedHealth Group Incorporated will post 27.6 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a $1.88 dividend. This represents a $7.52 annualized dividend and a dividend yield of 1.50%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

Analyst Upgrades and Downgrades

UNH has been the topic of a number of recent analyst reports. Wells Fargo & Company reduced their price target on shares of UnitedHealth Group from $600.00 to $525.00 and set an “overweight” rating on the stock in a research report on Monday, April 8th. StockNews.com downgraded UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Thursday, April 18th. HSBC upgraded UnitedHealth Group from a “reduce” rating to a “hold” rating and set a $460.00 target price for the company in a research note on Thursday, April 4th. Cantor Fitzgerald reissued an “overweight” rating and set a $591.00 price objective on shares of UnitedHealth Group in a report on Wednesday, April 10th. Finally, Erste Group Bank reissued a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Four equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $570.05.

Read Our Latest Stock Analysis on UNH

Insider Activity at UnitedHealth Group

In related news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now owns 9,364 shares of the company’s stock, valued at approximately $4,527,306.72. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total value of $451,127.82. Following the completion of the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by insiders.

UnitedHealth Group Profile

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Read More

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.